advanced cancer

2022 ASCO Annual Meeting; #ASCO22
June 5, 2022 · Leslie Fannon Zhang, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma. Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 4, 2022 · Brielle Gregory Collins, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer. Read More >>
March 15, 2022 · Amanda Nerstad
Lung cancer survivor Amanda Nerstad shares what it was like receiving a stage 4 diagnosis at age 39, the role genomic testing played in prolonging her quality of life, and how she and her family cope with the diagnosis. Read More >>
ASCO ® Plenary Series
March 14, 2022 · Brielle Gregory Collins, ASCO staff
Read research from the March 2022 session of the ASCO Plenary Series, which highlights an immunotherapy combination to treat advanced melanoma and adding immunotherapy to chemotherapy to treat advanced non-small cell lung cancer. Read More >>
March 3, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Funda Meric-Bernstam and Dr. Mark Robson discuss a new ASCO provisional clinical opinion on somatic genomic testing in people with metastatic or advanced cancer, including what it is and how it impacts cancer treatment. Read More >>

Pages